Cited by 301Chronic Kidney Disease and DiabetesDialysis and Renal Disease ManagementChronic Disease Management Strategies

The DOI matches its Crossref record; 32 of the 35 references it cites were found in a registry or an index.

The Future Burden of CKD in the United States: A Simulation Model for the CDC CKD Initiative

Open access

Hoerger, Thomas J., Simpson, Sean A., Yarnoff, Benjamin O., Pavkov, Meda E., Ríos Burrows, Nilka, Saydah, Sharon H., Williams, Desmond E., Zhuo, Xiaohui·2015·American Journal of Kidney Diseases

DOI 10.1053/j.ajkd.2014.09.023PMC PMC11000251

Open this paper in CoChat — free account

Abstract

Background Awareness of chronic kidney disease (CKD), defined by kidney damage or reduced glomerular filtration rate, remains low in the United States, and few estimates of its future burden exist.Study design We used the CKD Health Policy Model to simulate the residual lifetime incidence of CKD and project the prevalence of CKD in 2020 and 2030. The simulation sample was based on nationally representative data from the 1999 to 2010 National Health and Nutrition Examination Surveys.Setting & population Current US population.Model, perspective, & timeline Simulation model following up individuals from current age through death or age 90 years.Outcomes Residual lifetime incidence represents the projected percentage of persons who will develop new CKD during their lifetimes. Future prevalence is projected for 2020 and 2030.Measurements Development and progression of CKD are based on annual decrements in estimated glomerular filtration rates that depend on age and risk factors.Results For US adults aged 30 to 49, 50 to 64, and 65 years or older with no CKD at baseline, the residual lifetime incidences of CKD are 54%, 52%, and 42%, respectively. The prevalence of CKD in adults 30 years or older is projected to increase from 13.2% currently to 14.4% in 2020 and 16.7% in 2030.Limitations Due to limited data, our simulation model estimates are based on assumptions about annual decrements in estimated glomerular filtration rates.Conclusions For an individual, lifetime risk of CKD is high, with more than half the US adults aged 30 to 64 years likely to develop CKD. Knowing the lifetime incidence of CKD may raise individuals' awareness and encourage them to take steps to prevent CKD. From a national burden perspective, we estimate that the population prevalence of CKD will increase in coming decades, suggesting that development of interventions to slow CKD onset and progression should be considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.ajkd.2014.09.023

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors
Murray, C. J. L. (2013) · JAMA · doi:10.1001/jama.2013.13805 · Cited by 2,438
Cardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
Adler, A., Stevens, R., Manley, S. E., Bilous, R., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,800
Lifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515

Flagged first, then by citations

Show all 35 references

3 of the 35 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

2002, Kidney Disease Outcomes Quality Initiative: part 4. Definition and classification of stages of chronic kidney disease, Am J Kidney Dis, 39, S46
Hunink, 1997, The recent decline in mortality from coronary heart disease, 1980–1990, JAMA, 277, 535, 10.1001/jama.1997.03540310033031 · DOI

Sorted by citations

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
The Global Epidemiology of Diabetes and Kidney Disease
Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.10.011 · Cited by 686
Self-citation
Sleep deprivation and its association with diseases- a review
Liew, S. C., & Aung, T. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.07.048 · Cited by 341
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
Herrington, W. G., Preiss, D., Haynes, R., von Eynatten, M., Staplin, N., Hauske, S. J., George, J. T., Green, J. B., Landray, M. J., Baigent, C., et al. (2018) · Clinical Kidney Journal · doi:10.1093/ckj/sfy090 · Cited by 237
Automation of the kidney function prediction and classification through ultrasound-based kidney imaging using deep learning
Kuo, C., Chang, C.-M., Liu, K., Lin, W.-K., Chiang, H., Chung, C.-W., Ho, M.-R., Sun, P.-R., Yang, R.-L., & Chen, K.-T. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0104-2 · Cited by 227
The Renin Angiotensin Aldosterone System in Obesity and Hypertension
Cabandugama, P. K., Gardner, M. J., & Sowers, J. R. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.009 · Cited by 168
Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population
Covic, A. C., Vervloet, M. G., Massy, Z. A., Ureña, P., Goldsmith, D. J. A., Brandenburg, V. M., Mazzaferro, S., Evenepoel, P., Bover, J., Apetrii, M., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30310-8 · Cited by 164
Diet and Chronic Kidney Disease
Kramer, H. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz011 · Cited by 185
A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling
Yuan, Q., Ren, Q., Li, L., Tan, H., Lu, M., Tian, Y., Huang, L., Zhao, B., Fu, H., Hou, F. F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28096-z · Cited by 159
An Age-Calibrated Classification of Chronic Kidney Disease
Glassock, R. J., Delanaye, P., & Nahas, M. E. (2015) · JAMA · doi:10.1001/jama.2015.6731 · Cited by 132
Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database
Alfego, D., Ennis, J. L., Gillespie, B. S., Lewis, M. J., Montgomery, E., Ferrè, S., Vassalotti, J. A., & Letovsky, S. I. (2021) · Diabetes Care · doi:10.2337/dc21-0723 · Cited by 133
Nationwide Analysis of Persistent Type II Endoleak and Late Outcomes of Endovascular Abdominal Aortic Aneurysm Repair in Japan: A Propensity-Matched Analysis
Seike, Y., Matsuda, H., Shimizu, H., Ishimaru, S., Hoshina, K., Michihata, N., Yasunaga, H., & Komori, K. (2022) · Circulation · doi:10.1161/circulationaha.121.056581 · Cited by 129
Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
Tzoumas, N., Farrah, T. E., Dhaun, N., & Webb, D. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14920 · Cited by 113
Comprehensive Performance Assessment of Deep Learning Models in Early Prediction and Risk Identification of Chronic Kidney Disease
Akter, S., Habib, A., Islam, M. A., Hossen, M. S., Fahim, W. A., Sarkar, P. R., & Ahmed, M. (2021) · IEEE Access · doi:10.1109/access.2021.3129491 · Cited by 113
An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits.
Delanaye, P., Glassock, R. J., Pottel, H., & Rule, A. D. (2016) · Europe PMC (PubMed Central) · Cited by 110
Coffee Consumption and Kidney Function: A Mendelian Randomization Study
Kennedy, O. J., Pirastu, N., Poole, R., Fallowfield, J. A., Hayes, P. C., Grzeszkowiak, E. J., Taal, M. W., Wilson, J. F., Parkes, J., & Roderick, P. J. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.08.025 · Cited by 111
Mito‐TEMPO Alleviates Renal Fibrosis by Reducing Inflammation, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress
Liu, Y., Wang, Y., Ding, W. Q., & Wang, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5828120 · Cited by 99
The Rising Burden of Preeclampsia in the United States Impacts Both Maternal and Child Health
Peneva, D., Xu, X. J., Sutton, A. L. M., Triche, E. W., Ehrenkranz, R. A., Paidas, M. J., Stevens, W., & Shih, T. M. (2015) · American Journal of Perinatology · doi:10.1055/s-0035-1564881 · Cited by 103
Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages
Dad, T., & Weiner, D. E. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.06.003 · Cited by 102
Hospitalizations among adults with chronic kidney disease in the United States: A cohort study
Schrauben, S. J., Chen, H., Lin, E., Jepson, C., Yang, W. P., Scialla, J. J., Fischer, M. J., Lash, J. P., Fink, J. C., Hamm, L. L., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003470 · Cited by 103
Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic review
Puljak, L., Burilović, E., & Brković, T. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s103927 · Cited by 94
Risk of ESRD in the United States
Albertus, P., Morgenstern, H., Robinson, B. M., & Saran, R. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.05.030 · Cited by 91
NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease
Guo, H., Bi, X., Zhou, P., Zhu, S., & Ding, W. Q. (2017) · Mediators of Inflammation · doi:10.1155/2017/8316560 · Cited by 89
Association between health literacy and self-care behaviors among patients with chronic kidney disease
Wong, K. K., Velásquez, A., Powe, N. R., & Tuot, D. S. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0988-0 · Cited by 81
Prevalence and factors associated to chronic kidney disease in older adults
Amaral, T. L. M., Amaral, C. D. A., de Vasconcellos, M. T. L., & Monteiro, G. T. R. (2019) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2019053000727 · Cited by 83
Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease — A Population-Based Study
Wong, C. W., Lamoureux, E. L., Cheng, C., Cheung, C. M. G., Tai, E. S., Wong, T. Y., & Sabanayagam, C. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.023 · Cited by 78
ARIMA model for predicting chronic kidney disease and estimating its economic burden in China
Jian, Y., Zhu, D., Zhou, D., Li, N., Du, H., Xue, D. Q., Fu, X., Tao, D., & Han, B. (2022) · BMC Public Health · doi:10.1186/s12889-022-14959-z · Cited by 77
Cellular senescence in brain aging and cognitive decline
Shafqat, A., Khan, S., Omer, M. H., Niaz, M., Albalkhi, I., AlKattan, K. M., Yaqinuddin, A., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1281581 · Cited by 81
Use of Clinical Decision Support to Improve Primary Care Identification and Management of Chronic Kidney Disease (CKD)
Litvin, C. B., Hyer, J. M., & Ornstein, S. M. (2016) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2016.05.160020 · Cited by 71
Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
Yan, H., Xu, J., Xu, Z., Yang, B., Luo, P., & He, Q. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112115 · Cited by 73
Environment-Wide Association Study of CKD
Lee, J., Oh, S., Kang, H., Kim, S., Lee, G., Li, L., Kim, C. T., An, J. N., Oh, Y. K., Lim, C. S., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06780619 · Cited by 69
Prediabetes is associated with microalbuminuria, reduced kidney function and chronic kidney disease in the general population
Markus, M. R. P., Ittermann, T., Baumeister, S., Huth, C., Thorand, B., Herder, C., Roden, M., Siewert‐Markus, U., Rathmann, W., Köenig, W., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.12.005 · Cited by 69
Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway
Hallan, S. I., Øvrehus, M. A., Romundstad, S., Rifkin, D. E., Langhammer, A., Stevens, P. E., & Ix, J. H. (2016) · Kidney International · doi:10.1016/j.kint.2016.04.012 · Cited by 73
Losartan ameliorates renal interstitial fibrosis through metabolic pathway and Smurfs-TGF-β/Smad
Zou, J., Zhou, X., Ma, Y., & Yu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112931 · Cited by 66
The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds
Jonsson, A. J., Lund, S. H., Eriksen, B. O., Pálsson, R., & Indridason, Ó. S. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.017 · Cited by 68
How to tackle health literacy problems in chronic kidney disease patients? A systematic review to identify promising intervention targets and strategies
Boonstra, M. D., Reijneveld, S. A., Foitzik, E., Westerhuis, R., Navis, G. J., & de Winter, A. F. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa273 · Cited by 64
Prevalence and trends of chronic kidney disease and its risk factors among US adults: An analysis of NHANES 2003-18
Kibria, G. M. A., & Crispen, R. (2020) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2020.101193 · Cited by 64
Hypoxic preconditioning induces epigenetic changes and modifies swine mesenchymal stem cell angiogenesis and senescence in experimental atherosclerotic renal artery stenosis
Isik, B., Thaler, R., Goksu, B. N. B., Conley, S. M., Al-Khafaji, H., Mohan, A., Afarideh, M., Abumoawad, A., Zhu, X. Y., Krier, J. D., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02310-z · Cited by 63
Prevalence of chronic kidney disease in adults in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016
Hounkpatin, H. O., Harris, S., Fraser, S. D., Day, J., Mindell, J. S., Taal, M. W., O'Donoghue, D. J., & Roderick, P. J. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038423 · Cited by 62
The effects of short sleep duration on proteinuria and chronic kidney disease: a systematic review and meta-analysis
Cheungpasitporn, W., Thongprayoon, C., Suarez, M. L. G., Srivali, N., Ungprasert, P., Kittanamongkolchai, W., Caples, S. M., & Erickson, S. B. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw072 · Cited by 60
Medical Nutrition Therapy for Patients with Non–Dialysis-Dependent Chronic Kidney Disease: Barriers and Solutions
Kramer, H., Jimenez, E. Y., Brommage, D., Vassalotti, J. A., Montgomery, E., Steiber, A. L., & Schofield, M. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.05.023 · Cited by 61
Avaliação da função renal na população adulta brasileira, segundo critérios laboratoriais da Pesquisa Nacional de Saúde
Malta, D. C., Machado, Í. E., Pereira, C. A., Figueiredo, A. W., de Aguiar, L. K., de Almeida, W. D. S., de Souza, M. D. F. M., Rosenfeld, L. G., & Szwarcwald, C. L. (2019) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-549720190010.supl.2 · Cited by 61
The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
Initiative, O. B. O. T. C. F. D. C. A. P. C., Yarnoff, B. O., Hoerger, T. J., Simpson, S. K., Leib, A., Burrows, N. R., Shrestha, S. S., & Pavkov, M. E. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0497-6 · Cited by 55
Self-citation
Role of Gut-Derived Protein-Bound Uremic Toxins in Cardiorenal Syndrome and Potential Treatment Modalities
Lekawanvijit, S. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0749 · Cited by 51
Medical Nutrition Therapy for Chronic Kidney Disease Improves Biomarkers and Slows Time to Dialysis
de Waal, D., Heaslip, E., & CALLAS, P. W. (2015) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2015.08.002 · Cited by 51
Cost of renal replacement: how to help as many as possible while keeping expenses reasonable?
Vanholder, R. C., Lameire, N. H., Annemans, L., & Biesen, W. V. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv233 · Cited by 52
Rat Mesenchymal Stromal Cell Sheets Suppress Renal Fibrosis via Microvascular Protection
Imafuku, A., Oka, M., Miyabe, Y., Sekiya, S., Nitta, K., & Shimizu, T. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0113 · Cited by 51
Mesenchymal Stem/Stromal Cell–Derived Extracellular Vesicles for Chronic Kidney Disease: Are We There Yet?
Eirin, A., & Lerman, L. O. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.14596 · Cited by 51
Current progress in artificial intelligence-assisted medical image analysis for chronic kidney disease: A literature review
Zhao, D., Wang, W., Tang, T., Zhang, Y., & Yu, C. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.05.029 · Cited by 52
Arthrospira maxima (Spirulina) and C-phycocyanin prevent the progression of chronic kidney disease and its cardiovascular complications
Memije-Lazaro, I. N., Blas-Valdivia, V., Franco-Colín, M., & Cano-Europa, E. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.01.013 · Cited by 50
Soy-based renoprotection
McGraw, N., Krul, E. S., Grunz‐Borgmann, E. A., & Parrish, A. R. (2016) · World Journal of Nephrology · doi:10.5527/wjn.v5.i3.233 · Cited by 47
Small Vessels, Big Role
Chade, A. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08319 · Cited by 48
Albuminuria within the Normal Range Can Predict All-Cause Mortality and Cardiovascular Mortality
Kang, M., Kwon, S., Lee, J., Shin, J., Kim, Y. C., Park, J. Y., Bae, E., Kim, E. Y., Kim, D. K., Lim, C. S., et al. (2021) · Kidney360 · doi:10.34067/kid.0003912021 · Cited by 46
Recent trends in the prevalence of chronic kidney disease
Hsu, R. K., & Powe, N. R. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000315 · Cited by 49
Association of chronic kidney disease with exposure to polycyclic aromatic hydrocarbons in the US population
Rahman, H. H., Niemann, D., & Munson‐McGee, S. H. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17479-2 · Cited by 42
Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate
Graboski, A. L., Kowalewski, M. E., Simpson, J. B., Cao, X., Ha, M., Zhang, J., Walton, W. G., Flaherty, D. P., & Redinbo, M. R. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.07.015 · Cited by 44
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease
Tisdale, R. L., Cusick, M. M., Aluri, K. Z., Handley, T. J., Joyner, A. K. C., Salomon, J. A., Chertow, G. M., Goldhaber‐Fiebert, J. D., & Owens, D. K. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07311-5 · Cited by 42
Artificial intelligence-assisted repurposing of lubiprostone alleviates tubulointerstitial fibrosis
Samantasinghar, A., Ahmed, F., Rahim, C. S. A., Kim, K. H., Kim, S., & Choi, K. H. (2023) · Translational research · doi:10.1016/j.trsl.2023.07.010 · Cited by 42
Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study
Pérgola, P. E., Spiegel, D. M., Warren, S., Yuan, J., & Weir, M. R. (2017) · American Journal of Nephrology · doi:10.1159/000481270 · Cited by 40
Prediction of mortality among patients with chronic kidney disease: A systematic review
Hansrivijit, P., Chen, Y.-J., Lnu, K., Trongtorsak, A., Puthenpura, M. M., Thongprayoon, C., Bathini, T. J., Mao, M. A., & Cheungpasitporn, W. (2021) · World Journal of Nephrology · doi:10.5527/wjn.v10.i4.59 · Cited by 41
Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production
Wang, Y., Li, J., Chen, C., Lu, J., Yu, J., Xu, X., Peng, Y., Zhang, S., Jiang, S., Guo, J., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1823800 · Cited by 41
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
Yadav, P., Cockwell, P., Cook, M. A., Pinney, J. H., Giles, H. V., Aung, Y. S., Cairns, D. A., Owen, R. G., Davies, F. E., Jackson, G. H., et al. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0962-x · Cited by 38
Dietary methionine restriction modulates renal response and attenuates kidney injury in mice
Cooke, D., Ouattara, A., & Ables, G. P. (2017) · The FASEB Journal · doi:10.1096/fj.201700419r · Cited by 37
Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial
Wetmore, J. B., Kimber, C., Mahnken, J. D., & Stubbs, J. R. (2016) · British Journal Of Nutrition · doi:10.1017/s000711451600427x · Cited by 36
MiR‐145‐5p inhibits proliferation and inflammatory responses of RMC through regulating AKT/GSK pathway by targeting CXCL16
Wu, J., He, Y., Luo, Y., Zhang, L., Lin, H., Liu, X., Liu, B., Liang, C.-L., Zhou, Y., & Zhou, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26228 · Cited by 36
Evaluation of the Retinal Vasculature in Hypertension and Chronic Kidney Disease in an Elderly Population of Irish Nuns
McGowan, A., Silvestri, G., Moore, E., Silvestri, V., Patterson, C., Maxwell, A. P., & McKay, G. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136434 · Cited by 34
Co-occurrence of chronic kidney disease and glaucoma: Epidemiology and etiological mechanisms
Liu, W., Guo, R., Huang, D., Ji, J., Gansevoort, R. T., Snieder, H., & Jansonius, N. M. (2022) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2022.09.001 · Cited by 34
Hyperpolarized 13C magnetic resonance evaluation of renal ischemia reperfusion injury in a murine model
Baligand, C., Qin, H., True‐Yasaki, A., Gordon, J. W., von Morze, C., Santos, J. D., Wilson, D. M., Raffaı̈, R. L., Cowley, P. M., Baker, A. J., et al. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3765 · Cited by 34
A review on the efficacy and mechanism of action of Shenkang injection against chronic kidney disease
Zou, J., Zhou, X., Chen, Y.-K., Liu, J.-L., Wang, C., Ma, Y., & Wang, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110833 · Cited by 33
Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention
Lamprea-Montealegre, J. A., Shlipak, M. G., & Estrella, M. M. (2021) · Heart · doi:10.1136/heartjnl-2020-318004 · Cited by 32
Lifetime Risk of Stage 3–5 CKD in a Community-Based Sample in Iceland
Inker, L. A., Tighiouart, H., Aspelund, T., Gudnason, V. G., Harris, T. B., Indridason, Ó. S., Pálsson, R., Shastri, S., Levey, A. S., & Sarnak, M. J. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00180115 · Cited by 30
Moving closer to understanding the risks of living kidney donation
Steiner, R. W. (2015) · Clinical Transplantation · doi:10.1111/ctr.12652 · Cited by 31
Multi-Trajectory Models of Chronic Kidney Disease Progression.
Burckhardt, P., Nagin, D. S., & Padman, R. (2016) · PubMed Central · Cited by 31
Inhibition of fibronectin polymerization alleviates kidney injury due to ischemia-reperfusion
Bowers, S., Davis-Rodriguez, S., Thomas, Z. M., Rudman-Melnick, V., Bacon, W. C., Beiersdorfer, A., Ma, Q., Devarajan, P., & Blaxall, B. C. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00117.2019 · Cited by 31
Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease
Volodarskiy, A., Kumar, S., Amin, S., & Bangalore, S. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.06.046 · Cited by 31
The role of mitochondrial dysfunction in kidney injury and disease
Jia, X., Zhu, L., Zhu, Q., & Zhang, J. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103576 · Cited by 34
The Efficacy of a Nurse-Led Disease Management Program in Improving the Quality of Life for Patients with Chronic Kidney Disease: A Meta-Analysis
Chen, C.-C., Chen, Y., Liu, X., Wen, Y., Ma, D., Huang, Y., Pu, L., Diao, Y., & Yang, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155890 · Cited by 30
Estimated glomerular filtration rate and functional status among older people: A systematic review
Corsonello, A., Roller‐Wirnsberger, R., Rosa, M. D., Fabbietti, P., Wirnsberger, G. H., Kostka, T., Guligowska, A., Tap, L., Mattace-Raso, F. U. S., Gil, P., et al. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.05.030 · Cited by 59
Native vitamin D in pre-dialysis chronic kidney disease
Cardoso, M. P., & Pereira, L. (2018) · Nefrología · doi:10.1016/j.nefro.2018.07.004 · Cited by 30
Bidirectional Association Between Kidney Function and Atrial Fibrillation: A Population‐Based Cohort Study
van der Burgh, A. C., Geurts, S., Ikram, M. A., Hoorn, E. J., Kavousi, M., & Chaker, L. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025303 · Cited by 30
Protective role of Astragaloside IV in chronic glomerulonephritis by activating autophagy through PI3K / AKT / AS160 pathway
Lu, R., Chen, J., Liu, B., Lin, H., Bai, L., Zhang, P., Chen, D., Li, H., Li, J., Pang, Y., et al. (2020) · Phytotherapy Research · doi:10.1002/ptr.6772 · Cited by 28
CXA-10, a Nitrated Fatty Acid, Is Renoprotective in Deoxycorticosterone Acetate-Salt Nephropathy
ARBEENY, C. M., Ling, H., Smith, M. M., O’Brien, S., Wawersik, S., Ledbetter, S. R., McAlexander, A., Schopfer, F. J., Willette, R. N., & Jorkasky, D. K. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254755 · Cited by 28
Effect of cryotherapy on arteriovenous fistula puncture-related pain in hemodialysis patients: A systematic review and meta-analysis
Jafari-Koulaee, A., Moosazadeh, M., Bagheri‐Nesami, M., & Goudarzian, A. H. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102326 · Cited by 27
Potassium-Deficient Nutrient Solution Affects the Yield, Morphology, and Tissue Mineral Elements for Hydroponic Baby Leaf Spinach (Spinacia oleracea L.)
Levine, C. P., & Mattson, N. S. (2021) · Horticulturae · doi:10.3390/horticulturae7080213 · Cited by 27
Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective Cohort
Sánchez, J. J. G., James, G., Carrero, J. J., Arnold, M., Lam, C. S. P., Pollock, C. A., Chen, H., NOLAN, S. T., Wheeler, D. C., & Pecoits‐Filho, R. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.01.037 · Cited by 27
Awareness, self-management behaviors, health literacy and kidney function relationships in specialty practice
Devraj, R., Borrego, M. E., Vilay, A. M., Pailden, J., & Horowitz, B. (2018) · World Journal of Nephrology · doi:10.5527/wjn.v7.i1.41 · Cited by 27
Association of reduced inner retinal thicknesses with chronic kidney disease
Paterson, E., Ravindran, M. L., Griffiths, K., Velly, C., Cardwell, C. R., McCarter, R. V., Nicol, P., Chhablani, J. K., Rasheed, M. A., Vupparaboina, K. K., et al. (2020) · BMC Nephrology · doi:10.1186/s12882-019-1679-1 · Cited by 26
Preoperative Renal Insufficiency
Blitz, J. D., Shoham, M. H., Fang, Y., Narine, V., Mehta, N., Sharma, B. S., Shekane, P., & Kendale, S. M. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001573 · Cited by 26
Evaluation of Renal Oxygenation and Hemodynamics in Patients with Chronic Kidney Disease by Blood Oxygenation Level-dependent Magnetic Resonance Imaging and Intrarenal Doppler Ultrasonography
Yang, J., Yang, S., Xu, Y., Lü, F., You, L., He, Z., Zhan, S., Ye, C., Liu, M., Fu, C., et al. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000516637 · Cited by 25
Charting a Path Forward: Assessing the Science of Chemical Risk Evaluations under the Toxic Substances Control Act in the Context of Recent National Academies Recommendations
McPartland, J., Shaffer, R. M., Fox, M. A., Nachman, K. E., Burke, T. A., & Denison, R. A. (2022) · Environmental Health Perspectives · doi:10.1289/ehp9649 · Cited by 25
Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study
Yarnoff, B., Hoerger, T. J., Shrestha, S. S., Simpson, S. K., Burrows, N. R., Anderson, A. H., Xie, D., Chen, H., Pavkov, M. E., & the CRIC Study Investigators (2018) · PLoS ONE · doi:10.1371/journal.pone.0205530 · Cited by 23
Self-citation
Complications of Kidney Disease
Murabito, S., & Hallmark, B. F. (2018) · Nursing Clinics of North America · doi:10.1016/j.cnur.2018.07.010 · Cited by 23

Authors: Hoerger, T. J., Simpson, S. A., Yarnoff, B. O., Pavkov, M. E., Ríos Burrows, N., Saydah, S. H., Williams, D. E., & Zhuo, X.
Affiliations: RTI International (US)
Centers for Disease Control and Prevention (US)
Corresponding author: Hoerger, Thomas J.
ORCID: Hoerger, Thomas J.
Simpson, Sean A.
Yarnoff, Benjamin O.
Pavkov, Meda E.
Saydah, Sharon H.
Williams, Desmond E.
Venue: American Journal of Kidney Diseases
Publisher: Elsevier BV
Published: 2015-03
Volume: 65
Issue: 3
Pages: 403-411
ISSN: 0272-6386 (ISSN-L)
DOI: 10.1053/j.ajkd.2014.09.023
PMC: PMC11000251
OpenAlex: W2103852969
Cited by: 299
References: 35
Citations by year: 2026: 6 · 2025: 22 · 2024: 20 · 2023: 22 · 2022: 27 · 2021: 29 · 2020: 37 · 2019: 19 · 2018: 34 · 2017: 26 · 2016: 34 · 2015: 23
FWCI: 21.87
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: American Journal of Kidney Diseases (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (CC999999)
Topics: Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
Keywords: chronic kidney disease, estimated glomerular filtration rate decline, chronic kidney disease progression, CKD risk factors, CKD prevention
MeSH terms: Adult, Aged, Aged, 80 and over, Centers for Disease Control and Prevention, U.S., Female, Forecasting, Humans, Male, Middle Aged, Models, Theoretical, Nutrition Surveys, United States, Cohort Studies, Cost of Illness, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Future Burden of CKD in the United States: A Simulation Model for the CDC CKD Initiative

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks